Next Article in Journal
The Role of Cardiovascular and Metabolic Comorbidities in the Link between Atrial Fibrillation and Cognitive Impairment: An Appraisal of Current Scientific Evidence
Previous Article in Journal
A View of Human Immunodeficiency Virus Infections in the North-West Region of Romania
Open AccessCommunication

Indexes of Angiogenic Activation in Myocardial Samples of Patients with Advanced Chronic Heart Failure

1
Department of Medicine and Health Sciences, University of Molise, 86100 Campobasso, Italy
2
Pulmonary Rehabilitation Unit and Laboratory of Cytoimmunopathology of the Heart and Lung, Istituti Clinici Scientifici Maugeri, 28010 Veruno, Italy
3
Department of Clinical and Biological Sciences, University of Torino, San Luigi Hospital, 10043 Turin, Italy
4
Department of Cardiovascular and Thoracic Surgery, University of Turin, 10126 Turin, Italy
5
Division of Cardiology, Istituti Clinici Scientifici Maugeri, 28010 Veruno, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Medicina 2019, 55(12), 766; https://doi.org/10.3390/medicina55120766
Received: 4 October 2019 / Revised: 26 November 2019 / Accepted: 26 November 2019 / Published: 29 November 2019
Background and objectives: Ischemic and idiopathic heart failure are characterized by reactive cardiac fibrosis and impaired vasculogenesis involving pro-angiogenic factors such as angiogenin, angiopoietin-1 (Ang-1), and angiopoietin-2 (Ang-2), as demonstrated in experimental models of heart failure. However, differences in the molecular pathways between these cardiomyopathies are still unclear. In this short communication, we evaluate and compare the expression of pro-angiogenic molecules in the heart tissue of patients with advanced chronic heart failure (CHF) of ischemic vs. nonischemic etiology. Materials and Methods: We obtained heart tissue at transplantation from left ventricular walls of 16 explanted native hearts affected by either ischemic (ICM) or nonischemic dilated cardiomyopathy (NIDCM). Tissue samples were examined using immunohistochemistry for angiogenic molecules. Results: We found immunopositivity (I-pos) for angiopoietin-1 mainly in the cardiomyocytes, while we observed I-pos for Ang-2 and Tie-2 receptor mainly in endothelial cells. Expression of Procollagen-I (PICP), angiogenin, Ang-1, and Tie-2 receptor was similar in ICM and NIDCM. In contrast, endothelial immunopositivity for Ang-2 was higher in ICM samples than NIDCM (p = 0.03). Conclusions: In our series of CHF heart samples, distribution of Ang-1 and angiogenin was higher in cardiomyocytes while that of Ang-2 was higher in endothelial cells; moreover, Ang-2 expression was higher in ICS than NIDCM. Despite the small series examined, these findings suggest different patterns of angiogenic stimulation in ICM and NIDCM, or at least a more altered endothelial integrity in ICD. Our data may contribute to a better understanding of the angiogenesis signaling pathways in CHF. Further studies should investigate differences in the biochemical processes leading to heart failure. View Full-Text
Keywords: heart failure; angiogenesis; angiopoietin-1; angiopoietin-2; cardiac fibrosis heart failure; angiogenesis; angiopoietin-1; angiopoietin-2; cardiac fibrosis
Show Figures

Figure 1

MDPI and ACS Style

Komici, K.; Gnemmi, I.; Sangiorgi, C.; Ricciardolo, F.L.M.; Rinaldi, M.; Di Stefano, A.; Eleuteri, E. Indexes of Angiogenic Activation in Myocardial Samples of Patients with Advanced Chronic Heart Failure. Medicina 2019, 55, 766.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop